| 1 |
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析 [J]. 中华肿瘤杂志, 2019, 41(1): 19-28.
|
| 2 |
Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma [J]. Gastroenterology, 2018, 154(2): 360-373.
|
| 3 |
He Z, Liu Z, Liu M, et al. Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial [J]. Gut, 2019, 68(2): 198-206.
|
| 4 |
He Z, Zhao Y, Guo C, et al. Prevalence and risk factors for esophageal squamous cell cancer and precursor lesions in Anyang, China: a population-based endoscopic survey [J]. Br J Cancer, 2010, 103(7): 1085-1088.
|
| 5 |
Tran GD, Sun XD, Abnet CC, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China [J]. Int J Cancer, 2005, 113(3): 456-463.
|
| 6 |
Li JY, Chen ZJ, Ershow AG, et al. A case-control study of esophageal cancer in Linxian, People's Republic of China [J]. Natl Cancer Inst Monogr, 1985, 69: 5-7.
|
| 7 |
Li JY, Taylor PR, Li B, et al. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia [J]. J Natl Cancer Inst, 1993, 85(18): 1492-1498.
|
| 8 |
Wang SM, Abnet CC, Qiao YL. What have we learned from Linxian esophageal cancer etiological studies? [J]. Thorac Cancer, 2019, 10(5): 1036-1042.
|
| 9 |
Wei WQ, Abnet CC, Lu N, et al. Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China [J]. Gut, 2005, 54(6): 759-763.
|
| 10 |
Sheikh M, Poustchi H, Pourshams A, et al. Individual and combined effects of environmental risk factors for esophageal cancer based on results from the Golestan cohort study [J]. Gastroenterology, 2019, 156(5): 1416-1427.
|
| 11 |
Chen W, Li H, Ren J, et al. Selection of high-risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China [J]. Int J Cancer, 2020, 148(2): 329-339.
|
| 12 |
Liu M, Liu Z, Cai H, et al. A model to identify individuals at high risk for esophageal squamous cell carcinoma and precancerous lesions in regions of high prevalence in China [J]. Clin Gastroenterol Hepatol, 2017, 15(10): 1538-1546. e7.
|
| 13 |
Yu C, Tang H, Guo Y, et al. Hot tea consumption and its interactions with alcohol and tobacco use on the risk for esophageal cancer: a population-based cohort study [J]. Ann Intern Med, 2018, 168(7): 489-497.
|
| 14 |
Tuyns AJ, Masse G. Cancer of the oesophagus in Brittany: an incidence study in Ille-et-Vilaine [J]. Int J Epidemiol, 1975, 4(1): 55-59.
|
| 15 |
Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers [J]. J Natl Cancer Inst, 2003, 95(18): 1404-1413.
|
| 16 |
Arnold M, Soerjomataram I, Ferlay J, et al. Global incidence of oesophageal cancer by histological subtype in 2012 [J]. Gut, 2015, 64(3): 381-387.
|
| 17 |
GBD 2017 Oesophageal Cancer Collaborators. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J]. Lancet Gastroenterol Hepatol, 2020, 5(6): 582-597.
|
| 18 |
Di Pilato V, Freschi G, Ringressi MN, et al. The esophageal microbiota in health and disease [J]. Ann N Y Acad Sci, 2016, 1381(1): 21-33.
|
| 19 |
Yu G, Gail MH, Shi J, et al. Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach [J]. Cancer Epidemiol Biomarkers Prev, 2014, 23(5): 735-741.
|
| 20 |
Vogtmann E, Flores R, Yu G, et al. Association between tobacco use and the upper gastrointestinal microbiome among Chinese men [J]. Cancer Causes Control, 2015, 26(4): 581-588.
|
| 21 |
Chen X, Winckler B, Lu M, et al. Oral microbiota and risk for esophageal squamous cell carcinoma in a high-risk area of China [J]. PLoS One, 2015, 10(12): e0143603.
|
| 22 |
Nasrollahzadeh D, Malekzadeh R, Ploner A, et al. Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia [J]. Sci Rep, 2015, 5: 8820.
|
| 23 |
Yamamura K, Izumi D, Kandimalla R, et al. Intratumoral fusobacterium nucleatum levels predict therapeutic response to neoadjuvant chemotherapy in esophageal squamous cell carcinoma [J]. Clin Cancer Res, 2019, 25(20): 6170-6179.
|
| 24 |
Shao D, Vogtmann E, Liu A, et al. Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China [J]. Cancer, 2019, 125(22): 3993-4002.
|
| 25 |
Robert LG, Dimaio D. The papillomaviruses [M]. New York: Springer, 2007.
|
| 26 |
Liu F, Guo F, Zhou Y, et al. The anyang esophageal cancer cohort study: study design, implementation of fieldwork, and use of computer-aided survey system [J]. PLoS One, 2012, 7(2): e31602.
|
| 27 |
Liu M, Liu F, Pan Y, et al. Viral load in the natural history of human papillomavirus infection among men in rural China: a population-based prospective study [J]. Clin Infect Dis, 2018, 67(12): 1861-1867.
|
| 28 |
Hang D, Liu F, Liu M, et al. Oral human papillomavirus infection and its risk factors among 5,410 healthy adults in China, 2009-2011 [J]. Cancer Epidemiol Biomarkers Prev, 2014, 23(10): 2101-2110.
|
| 29 |
Liu M, He Z, Zhang C, et al. Prevalence, incidence, clearance, and associated factors of genital human papillomavirus infection among men: a population-based cohort study in rural China [J]. Cancer Epidemiol Biomarkers Prev, 2014, 23(12): 2857-2865.
|
| 30 |
Deng Q, Li J, Pan Y, et al. Prevalence and associated risk factors of human papillomavirus in healthy skin specimens collected from rural Anyang, China, 2006-2008 [J]. J Invest Dermatol, 2016, 136(6): 1191-1198.
|
| 31 |
Abnet CC, Freedman ND, Hu N, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma [J]. Nat Genet, 2010, 42(9): 764-767.
|
| 32 |
Wang LD, Zhou FY, Li XM, et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54 [J]. Nat Genet, 2010, 42(9): 759-763.
|
| 33 |
Wu C, Hu Z, He Z, et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations [J]. Nat Genet, 2011, 43(7): 679-684.
|
| 34 |
Abnet CC, Wang Z, Song X, et al. Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies [J]. Hum Mol Genet, 2012, 21(9): 2132-2141.
|
| 35 |
Wu C, Kraft P, Zhai K, et al. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions [J]. Nat Genet, 2012, 44(10): 1090-1097.
|
| 36 |
Wu C, Wang Z, Song X, et al. Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations [J]. Nat Genet, 2014, 46(9): 1001-1006.
|
| 37 |
Dai J, Lv J, Zhu M, et al. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations [J]. Lancet Respir Med, 2019, 7(10): 881-891.
|
| 38 |
Jin G, Lv J, Yang M, et al. Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study [J]. Lancet Oncol, 2020, 21(10): 1378-1386.
|
| 39 |
Agrawal N, Jiao Y, Bettegowda C, et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma [J]. Cancer Discov, 2012, 2(10): 899-905.
|
| 40 |
Gao YB, Chen ZL, Li JG, et al. Genetic landscape of esophageal squamous cell carcinoma [J]. Nat Genet, 2014, 46(10): 1097-1102.
|
| 41 |
Lin DC, Hao JJ, Nagata Y, et al. Genomic and molecular characterization of esophageal squamous cell carcinoma [J]. Nat Genet, 2014, 46(5): 467-473.
|
| 42 |
Song Y, Li L, Ou Y, et al. Identification of genomic alterations in oesophageal squamous cell cancer [J]. Nature, 2014, 509(7498): 91-95.
|
| 43 |
Wang Q, Bai J, Abliz A, et al. An old story retold: loss of G1 control defines a distinct genomic subtype of esophageal squamous cell carcinoma [J]. Genomics, Proteomics Bioinformatics, 2015, 13(4): 258-270.
|
| 44 |
Zhang L, Zhou Y, Cheng C, et al. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma [J]. Am J Hum Genet, 2015, 96(4): 597-611.
|
| 45 |
Hao JJ, Lin DC, Dinh HQ, et al. Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma [J]. Nat Genet, 2016, 48(12): 1500-1507.
|
| 46 |
Sawada G, Niida A, Uchi R, et al. Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population [J]. Gastroenterology, 2016, 150(5): 1171-1182.
|
| 47 |
Qin HD, Liao XY, Chen YB, et al. Genomic characterization of esophageal squamous cell carcinoma reveals critical genes underlying tumorigenesis and poor prognosis [J]. Am J Hum Genet, 2016, 98(4): 709-727.
|
| 48 |
Hu N, Kadota M, Liu H, et al. Genomic landscape of somatic alterations in esophageal squamous cell carcinoma and gastric cancer [J]. Cancer Res, 2016, 76(7): 1714-1723.
|
| 49 |
Cancer Genome Atlas Research N, Analysis Working Group: Asan U, Agency BCC, et al. Integrated genomic characterization of oesophageal carcinoma [J]. Nature, 2017, 541(7636): 169-175.
|
| 50 |
Liu X, Zhang M, Ying S, et al. Genetic alterations in esophageal tissues from squamous dysplasia to carcinoma [J]. Gastroenterology, 2017, 153(1): 166-177.
|
| 51 |
Chen XX, Zhong Q, Liu Y, et al. Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing [J]. Nat Commun, 2017, 8(1): 524.
|
| 52 |
Chang J, Tan W, Ling Z, et al. Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations [J]. Nat Commun, 2017, 8(1): 15290.
|
| 53 |
Yuan W, Liu Z, Wang Y, et al. Clonal evolution of esophageal squamous cell carcinoma from normal mucosa to primary tumor and metastases [J]. Carcinogenesis, 2019, 40(12): 1445-1451.
|
| 54 |
Park S, Joung JG, Min YW, et al. Paired whole exome and transcriptome analyses for the immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma [J]. J Immunother Cancer, 2019, 7(1): 128.
|
| 55 |
Dutta M, Nakagawa H, Kato H, et al. Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma [J]. Peer J, 2020, 8: e9294.
|
| 56 |
Cui Y, Chen H, Xi R, et al. Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma [J]. Cell Res, 2020, 30(10): 902-913.
|
| 57 |
王贵齐, 魏文强. 上消化道癌筛查和早诊早治项目的新转变:机会性筛查 [J]. 中华预防医学杂志, 2019, 53(11): 1084-1087.
|
| 58 |
Wei WQ, Hao CQ, Guan CT, et al. Esophageal Histological Precursor Lesions and Subsequent 8.5-Year Cancer Risk in a Population-Based Prospective Study in China [J]. Am J Gastroenterol, 2020, 115(7): 1036-1044.
|
| 59 |
Liu M, Liu Z, Cai H, et al. A Model To identify individuals at high risk for esophageal squamous cell carcinoma and precancerous lesions in regions of high prevalence in China [J]. Clin Gastroenterol Hepatol, 2017, 15(10): 1538-1546.
|
| 60 |
Liu M, Liu Z, Liu F, et al. Absence of iodine staining associates with progression of esophageal lesions in a prospective endoscopic surveillance study in China [J]. Clin Gastroenterol Hepatol, 2020, 18(7): 1626-1635.
|
| 61 |
Liu M, Zhou R, Guo C, et al. Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus [J]. Gastrointest Endosc, 2021, 93(5): 1065-1073.
|
| 62 |
Yip CH. Downstaging is more important than screening for asymptomatic breast cancer [J]. Lancet Glob Health, 2019, 7(6): e690-e691.
|
| 63 |
Wang J, Liu F, Gao H, et al. The symptom-to-treatment delay and stage at the time of treatment in cancer of esophagus [J]. Jpn J Clin Oncol, 2008, 38(2): 87-91.
|
| 64 |
Dos-Santos-Silva I, De Stavola BL, Renna NLJ, et al. Ethnoracial and social trends in breast cancer staging at diagnosis in Brazil, 2001-14: a case only analysis [J]. Lancet Glob Health, 2019, 7(6): e784-e797.
|
| 65 |
Liu Z, Guo C, He Y, et al. A clinical model predicting the risk of esophageal high-grade lesions in opportunistic screening: a multicenter real-world study in China [J]. Gastrointest Endosc, 2020, 91(6): 1253-1260.
|
| 66 |
Gupta V, Coburn N, Kidane B, et al. Survival prediction tools for esophageal and gastroesophageal junction cancer: A systematic review [J]. J Thorac Cardiovasc Surg, 2018, 156(2): 847-856.
|
| 67 |
Deng W, Zhang W, Yang J, et al. Nomogram to predict overall survival for thoracic esophageal squamous cell carcinoma patients after radical esophagectomy [J]. Ann Surg Oncol, 2019, 26(9): 2890-2898.
|
| 68 |
Du F, Sun Z, Jia J, et al. Development and validation of an individualized nomogram for predicting survival in patients with esophageal carcinoma after resection [J]. J Cancer, 2020, 11(14): 4023-4029.
|
| 69 |
Liu F, Zhou R, Jiang F, et al. Proposal of a nomogram for predicting survival in patients with siewert type II adenocarcinoma of the esophagogastric junction after preoperative radiation [J]. Ann Surg Oncol, 2019, 26(5): 1292-1300.
|